Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

被引：0
作者：
C Palmieri
O Gojis
B Rudraraju
C Stamp-Vincent
D Wilson
S Langdon
C Gourley
D Faratian
机构：
[1] Institute of translational Medicine,Department of Molecular and Clinical Cancer Medicine
[2] University of Liverpool,Division of Cancer
[3] Cancer Research UK Laboratories,Edinburgh Breakthrough Research Unit and Division of Pathology
[4] Imperial College London,undefined
[5] Du Cane Road,undefined
[6] London,undefined
[7] UK,undefined
[8] University of Edinburgh,undefined
[9] University of Edinburgh Cancer Research UK Centre,undefined
[10] Institute of Genetics and Molecular Medicine,undefined
[11] University of Edinburgh,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
ovarian cancer; SRC3; platinum; resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2039 / 2044
页数：5
相关论文
共 50 条
  • [41] Annexin A3 Is a Potential Predictor of Platinum Resistance in Epithelial Ovarian Cancer Patients in a Prospective Cohort
    Jin, Ying
    Feng, Li-ping
    Jiang, Xiang
    Wang, Yong-xue
    Yin, Jie
    Yang, Zi-ping
    Li, Yan
    Pan, Ling-ya
    JOURNAL OF CANCER, 2015, 6 (07): : 678 - 685
  • [42] Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer
    G. K. Siddiqui
    A. B. Maclean
    K. Elmasry
    A. Wong te Fong
    R. W. Morris
    M. Rashid
    R. H. J. Begent
    G. M. Boxer
    Angiogenesis, 2011, 14 : 155 - 161
  • [43] Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer
    Siddiqui, G. K.
    Maclean, A. B.
    Elmasry, K.
    Fong, A. Wong Te
    Morris, R. W.
    Rashid, M.
    Begent, R. H. J.
    Boxer, G. M.
    ANGIOGENESIS, 2011, 14 (02) : 155 - 161
  • [44] Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
    Christoph Scholz
    Sabine Heublein
    Miriam Lenhard
    Klaus Friese
    Doris Mayr
    Udo Jeschke
    BMC Research Notes, 5 (1)
  • [45] PLATINUM TAXOL NON-CROSS RESISTANCE IN EPITHELIAL OVARIAN-CANCER
    GORE, ME
    PRESTON, N
    AHERN, RP
    HILL, C
    MITCHELL, P
    CHANG, J
    NICOLSON, M
    BRITISH JOURNAL OF CANCER, 1995, 71 (06) : 1308 - 1310
  • [46] Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer
    Song, Taejong
    Choi, Chel Hun
    Cho, Young Jae
    Sung, Chang Ohk
    Song, Sang Yong
    Kim, Tae-Joong
    Bae, Duk-Soo
    Lee, Jeong-Won
    Kim, Byoung-Gie
    GYNECOLOGIC ONCOLOGY, 2012, 125 (02) : 427 - 432
  • [47] Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
    Choi, Chel Hun
    Kang, Tae Heung
    Song, Joon Seon
    Kim, Young Seob
    Chung, Eun Joo
    Ylaya, Kris
    Kim, Seokho
    Koh, Sang Seok
    Chung, Joon-Yong
    Kim, Jae-Hoon
    Hewitt, Stephen M.
    SCIENTIFIC REPORTS, 2018, 8
  • [48] The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
    P M O'Brien
    M J Davies
    J P Scurry
    A N Smith
    C A Barton
    M J Henderson
    D N Saunders
    B S Gloss
    K I Patterson
    J L Clancy
    V A Heinzelmann-Schwarz
    R A Scolyer
    Y Zeng
    E D Williams
    L Scurr
    A DeFazio
    D I Quinn
    C K W Watts
    N F Hacker
    S M Henshall
    R L Sutherland
    British Journal of Cancer, 2008, 98 : 1085 - 1093
  • [49] Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
    Papadaki, Chara
    Manolakou, Stavroula
    Lagoudaki, Eleni
    Pontikakis, Spyros
    Ierodiakonou, Despo
    Vogiatzoglou, Konstantinos
    Messaritakis, Ippokratis
    Trypaki, Maria
    Giannikaki, Linda
    Sfakianaki, Maria
    Kalykaki, Antonia
    Mavroudis, Dimitrios
    Tzardi, Maria
    Souglakos, John
    CANCERS, 2020, 12 (04)
  • [50] miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
    Xiaotang Yu
    Xinchen Zhang
    Guang Wang
    Bo Wang
    Yanfang Ding
    Jinyao Zhao
    Hanlin Liu
    Shiying Cui
    Cancer Cell International, 20
12345